🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
Researchers are looking for new ways to treat Limited-Stage Small Cell Lung...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0007)
Start Date
2020-12-08
Trial ID
NCT04624204
This novel study was specifically designed for platinum resistant recurrent...
Status
Withdrawn
Location
Menoufia University, Faculty of medicine
Start Date
2021-04-01
Trial ID
NCT04795596
Treatments Being Tested
This is a randomized, open label, multicenter phase III trial comparing the...
Status
Completed
Location
Moores UC San Diego Cancer Center
Start Date
2019-05-09
Trial ID
NCT03570892
The study is intended to assess the safety and efficacy of perioperative tr...
Status
Recruiting
Location
Research Site
Start Date
2022-04-14
Trial ID
NCT05061550
98 participants will be randomly assigned 1:1 to the experimental group and...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-12-20
Trial ID
NCT06703398
Treatments Being Tested
The goal of this study is to understand whether CRB-701, a targeted form of...
Status
Not Yet Recruiting
Location
The University of Arizona Cancer Center
Start Date
2026-09-20
Trial ID
NCT07768189
Treatments Being Tested
The study is being conducted to evaluate the efficacy, and safety of SHR-A1...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2024-07-29
Trial ID
NCT06430437
Treatments Being Tested
The purpose of this study is to evaluate the safety, pharmacokinetics (PK),...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2023-06-20
Trial ID
NCT05789082
Treatments Being Tested
This study specifically aims to evaluate how well mocertatug rezetecan (Mo-...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-06-18
Trial ID
NCT07286266